Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia
AMX-883, Amphista’s first asset to enter the clinic, is a potent, selective, orally bioavailable DCAF16-mediated BRD9 degrader targeting acute myeloid leukemia (AML) The first-in-human ‘BRAMLIE’ (BR(D9) AML Interventional Evaluation) trial will assess the safety, p
Guardtech gearing up for an action-packed 2026 exhibition finale
The contamination control specialists prepare for a busy autumn schedule across Healthcare, Pharmaceutical and Biotechnology events.
People’s Choice: Vote now in memory of 5-year-old Alfred
A tribute to a 5-year-old and his ‘pet potato’, Alfred’s Potato Day is in the running for a charity ‘Oscar’ and needs your votes!
Helping innovation grow: The EpiCentre rewards laboratory space referrals with £500
Building a strong innovation community often starts with a single introduction. Recognising the value of these connections, The EpiCentre in Haverhill, Suffolk, has announced a new referral scheme that rewards individuals and organisations for introducing businesses seeking laboratory space.
o2h Technology launches Tech Kickstarter 5.0 for seed and early-stage companies
More than 100 start-up applications have previously applied to the Tech Kickstarter competition, with 13 winners selected, spanning life sciences, tech and AI, and green innovation.
ELRIG and The Protein Society announce keynote speakers for protein sciences in Drug Discovery 2026
• Prof Dame Carol Robinson (University of Oxford), Dr Andrew Doré (Isomorphic Labs) and Prof Paula Booth (King’s College London) to lead event taking place from 10–11 November at GSK Stevenage • Programme to focus on AI, machine learning and data-driven approaches across protein design, characterisation and therapeutic development
Carterra advances lab-in-the-loop drug discovery through new scientific collaboration
Bringing together scientific and technical expertise to advance development of hardware and software aimed at enabling a new wave of AI-driven, autonomous biologics discovery
Cresset launches Flare AI Client, helping computational chemists complete hours of work in minutes
Scientists can now connect company-approved AI providers such as Claude Code and GitHub Copilot directly to Flare, helping teams set up, execute, and analyze complex computational chemistry workflows in minutes not hours.
Is fear stalling your career, or your team?
You're good at what you do, but right now something feels different. Perhaps redundancy has arrived, or you sense it's coming. Or perhaps you're the HR leader who has to tell good people their roles are at risk. Wherever you sit, fear is part of the picture. In this article, I share what I see in my coaching work and practical ways to stop fear stalling your career or your team.
Why many B2B content strategies stop delivering results
Most B2B companies produce content consistently, but fewer step back and assess whether that content is actually helping the business grow.
Group A Streptococcus: vaccines are now back on the agenda
VacZine Analytics, a specialist publisher in vaccines, has released a new independent commercial forecast for Group A Streptococcus (GAS) vaccines, now that two industry candidates have entered clinical trials.
Are we still solving the problem we started with?
By Lily Lin, CEO, Excellence First Enterprise Consultancy (EFEC), and Founder, CognateUK.
Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027
· o2h co-discovery to host second edition of the Cambridge x London Life Sciences Showcase, taking place on 13 January 2027 at 111 Minna Gallery, San Francisco
Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery
· Nature Biotechnology publication details improved calibration framework for deep learning-based genetic perturbation models
CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium
Four sessions across twodays focusing on key drug discovery and development application areas of organ-on-a-chip technologies Expert-led presentations and panel discussions featuring leaders across research, regulatory and industry, including Novo
Laverock Therapeutics announces in vivo programmes in oncology and genetic medicine
Laverock's programmable gene control platform unlocks in vivo therapeutics with enhanced efficacy and safety
Cambridge Forum brings global leaders together to turn AI innovation into impact
Cambridge, UK – September 2026: Cambridge Forum brought together around 200 delegates from the UK and overseas at Cambridge Corn Exchange on 10th and 11th September, creating a multidisciplinary meeting place for some of the most pressing conversations around AI, health and the responsible use of technology.
Cytotrait appoints Dr Ian Jepson as Non-Executive Director
Accomplished international R&D executive, previously Syngenta, specialising in biotech trait development and genome editing technologiesFollows £3M seed round in 20261 to expand capabilities of the Company’s core MOSS platform and establish trait enhancem
AstraZeneca announces strategic equity investment and clinical collaboration with Summit Therapeutics to advance leading ADC combination strategy in cancer
Clinical collaboration will evaluate sonesitatug vedotin, a Claudin-18.2 ADC, with ivonescimab, a first-in-class PD-1/VEGF bispecific, in gastrointestinal cancers
Why the Cambridge region is becoming an increasingly important focal point for UK medical technology
The Cambridge region has long been recognised as one of the UK’s strongest centres for science, technology and life sciences. What makes the area particularly interesting for medical technology is the way those disciplines increasingly overlap.
Why omnichannel lead strategies matter in complex B2B markets
Many B2B companies operate across multiple marketing channels, yet prospects often experience those channels as disconnected.
Cambridge Mind and Brain Institute launches to address challenges facing our brain health
Cambridge announces a new institute focused on understanding and improving brain health across our lifespan, from early childhood through to old age.
PhiZ & Co will be at this year’s RAREsummit
On Wednesday 7 October 2026, 300 minds from across the rare disease community will gather at the Wellcome Genome Campus for the 8th RAREsummit – a unique opportunity to make connections, exchange ideas, and openly debate possibilities. If you work in rare disease science, healthcare, research, innovation, policy, funding, advocacy, or live with a rare condition, this is an event not to be missed…
Particle counters – a small change that could have a huge impact on your controlled environment efficiencies
East Anglian contamination control specialists Guardtech urging applications across Life Sciences, High-Tech Engineering and Healthcare to consider positive effects continuous monitoring can have for on-going cleanroom performance as well as operational success
Built by one person, relied on by many: small AI tools in life sciences organisations
By Lily Lin, CEO, Excellence First Enterprise Consultancy.